Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant human platelet derived growth factor BB |
---|---|
Date Designated: | 02/01/2007 |
Orphan Designation: | Treatment of osteonecrosis of the jaws |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Luitpold Pharmaceuticals, Inc. 800 Adams Avenue Suite 100 Norristown, Pennsylvania 19403 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-